TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹445 Cr | ₹393 Cr | ₹369 Cr | ₹370 Cr | ₹338 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹445 Cr |
Mar2023 | ₹393 Cr |
Mar2022 | ₹369 Cr |
Mar2021 | ₹370 Cr |
Mar2020 | ₹338 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹445 Cr | 13.14 | |
Mar2023 | ₹393 Cr | 6.60 | |
Mar2022 | ₹369 Cr | -0.24 | |
Mar2021 | ₹370 Cr | 9.25 | |
Mar2020 | ₹338 Cr | - |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹107,203.4 Cr | -1% | -0.5% | 13.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
MANKIND PHARMA | ₹95,866.6 Cr | -1.4% | -7.7% | 5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -1% |
-0.5% |
13.2% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses